期刊
JOURNAL OF NEUROCHEMISTRY
卷 120, 期 1, 页码 157-164出版社
WILEY
DOI: 10.1111/j.1471-4159.2011.07275.x
关键词
Akt; Alzheimer disease; GSK-3beta; neuroglobin; tau hyperphosphorylation
资金
- Natural Science Foundation of China [30800342, 30971478]
Neuroglobin (Ngb) is a recently identified member of hemoglobin family, distributed mainly in central and peripheral nervous systems. Recent studies suggest that Ngb can protect neural cells from beta-amyloid-induced toxicity in Alzheimer disease (AD). Hyperphosphorylation of tau is another characterized pathological hallmark in the AD brains; however, it is not reported whether Ngb also affects tau phosphorylation. In this study, we found that the level of Ngb was significantly reduced in Tg2576 mice (a recognized mouse model of AD) and TgMAPt mice, and the level of Ngb was negatively correlated with tau phosphorylation. Over-expression of Ngb attenuates tau hyperphosphorylation at multiple AD-related sites induced by up-regulation of glycogen synthase kinase-3 beta (GSK-3 beta), a crucial tau kinase. While Ngb activates Akt and thus inhibits GSK-3 beta, simultaneously inhibition of Akt abolishes the effects of Ngb on GSK-3 beta inhibition and tau hyperphosphorylation. Our data indicate that Ngb may attenuate tau hyperphosphorylation through activating Akt signaling pathway, implying a therapeutic target for AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据